Microvesicle Isolation for Collagen VII Delivery in Epidermolysis Bullosa
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective methods and compositions to treat epidermolysis bullosa, particularly dystrophic epidermolysis bullosa, which causes severe blistering and scarring, leading to complications such as SCC and premature mortality, due to mutations in the COL7A1 gene affecting collagen VII production.
Innovation Solution
Isolation and administration of microvesicles, such as extracellular vesicles, from biological fluids using agents like calcium, magnesium, or polyethylene glycol to treat epidermolysis bullosa, enhancing collagen VII expression and alleviating symptoms by delivering collagen VII protein and mRNA, as well as other bioactive agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional isolation methods (ultracentrifugation, filtration) are used to obtain collagen VII, then the skin fragility and blistering symptoms of epidermolysis bullosa patients can be addressed, but the structural and functional integrity of the isolated microvesicles is damaged
Solution Approach 1:
The patent changes the physical-chemical parameters of the isolation process by using precipitation with polyethylene glycol instead of high-speed ultracentrifugation or harsh filtration. This alternative parameter set (precipitation conditions, polymer concentration, temperature, pH) allows microvesicle isolation while preserving their structural integrity and functional contents, directly resolving the contradiction between reliable isolation and process damage
Solution Approach 2:
The patent introduces polyethylene glycol as an intermediary substance that mediates the isolation process. Rather than directly applying mechanical force (ultracentrifugation) or physical barriers (filtration) that damage microvesicles, the polymer acts as a gentle precipitating agent that allows microvesicles to be recovered intact, thus resolving the contradiction between effective isolation and preservation of integrity
2Reliability
If collagen VII is administered to treat dystrophic epidermolysis bullosa, then symptoms like blistering and scarring can be alleviated, but the treatment complexity and cost increase due to the need for specialized delivery systems
Solution Approach 1:
The patent employs microvesicles that naturally contain collagen VII and related bioactive molecules, allowing the therapeutic system to be self-contained. The microvesicles serve as both the delivery vehicle and the source of therapeutic cargo, eliminating the need for complex external delivery infrastructure and reducing overall treatment system complexity while maintaining effectiveness
Solution Approach 2:
The patent uses microvesicles that can simultaneously deliver multiple therapeutic agents (collagen VII, growth factors, other bioactive molecules) and provide protective functions (shielding from immune clearance, enhancing tissue penetration). This multi-functionality reduces the need for separate delivery systems for different therapeutics, thereby simplifying the overall treatment approach while maintaining comprehensive therapeutic effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method increases collagen VII production, reduces blistering, and alleviates symptoms like blistering, scarring, and infection, improving the quality of life and survival of patients with epidermolysis bullosa.
Implementation Method 1
isolated microvesicles are extracellular vesicles that are optionally precipitated from a biological fluid using a precipitating agent selected from the group consisting of calcium ions, magnesium ions, sodium ions, ammonium ions, iron ions, ammonium sulfate, alginate, and polyethylene glycol
Data Source
AI summary
The present invention provides compositions and methods for treating epidermolysis bullosa.